All stock lists
Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
89.10-1.80 (-1.98%)
Insider Score
––Not scored
RYTM Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
RYTM Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 71.25 M | 60.11 M | 57.25 M | 51.30 M | 48.50 M |
| Revenue Growth (YoY) | 46.91 % | — | — | — | — |
| Cost of Revenue | 8.93 M | 7.16 M | 4.80 M | 5.50 M | 5.54 M |
| Gross Profit | 62.32 M | 52.95 M | 52.45 M | 45.80 M | 42.96 M |
| SG&A Expense | 67.45 M | 63.59 M | 57.48 M | 52.42 M | 45.95 M |
| R&D Expense | 43.43 M | 41.73 M | 42.03 M | 46.03 M | 42.31 M |
| Operating Expenses | 110.88 M | 105.32 M | 99.51 M | 98.45 M | 88.25 M |
| Operating Income | -48.55 M | -52.36 M | -47.06 M | -52.65 M | -45.30 M |
| Pretax Income | -48.85 M | -55.09 M | -47.54 M | -52.79 M | -46.30 M |
| Tax Provision | 444.00 K | 545.00 K | -31.00 K | 111.00 K | 337.00 K |
| Net Income | -49.30 M | -55.64 M | -47.51 M | -52.90 M | -46.63 M |
| EPS (Basic) | -0.73 | -0.83 | -0.73 | -0.82 | -0.75 |
| EPS (Diluted) | -0.73 | -0.83 | -0.73 | -0.82 | -0.75 |
| Shares Outstanding | 68.59 M | 67.97 M | 66.88 M | 66.26 M | 63.68 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.